These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22932454)

  • 21. [Neuroendocrine tumors of digestive system: morphologic spectrum and cell proliferation (Ki67 index)].
    Delektorskaia VV; Kushliskiĭ NE
    Vestn Ross Akad Med Nauk; 2013; (5):28-37. PubMed ID: 24000665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.
    Strosberg J; Nasir A; Coppola D; Wick M; Kvols L
    Hum Pathol; 2009 Sep; 40(9):1262-8. PubMed ID: 19368957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The significance of CD44 expression in gastrointestinal neuroendocrine tumors.
    Lai CH; Shan YS; Sy ED; Hsieh YH; Tsai HW; Lee JC; Lin PW
    Hepatogastroenterology; 2005; 52(64):1071-6. PubMed ID: 16001632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms].
    Liang WQ; Zhang W; Qiao S; Wang BH; Wang C; Zhuang ZW; Xi HQ; Cai AZ; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):38-43. PubMed ID: 31958929
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of WHO 2000 and WHO 2010 classifications of gastroenteropancreatic neuroendocrine tumors.
    Karakuş E; Helvacı A; Ekinci O; Dursun A
    Turk J Gastroenterol; 2014 Feb; 25(1):81-7. PubMed ID: 24918137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is neuroendocrine differentiation a prognostic factor in poorly differentiated colorectal cancer?
    Chen Y; Liu F; Meng Q; Ma S
    World J Surg Oncol; 2017 Mar; 15(1):71. PubMed ID: 28351413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer.
    Grabowski P; Schindler I; Anagnostopoulos I; Foss HD; Riecken EO; Mansmann U; Stein H; Berger G; Buhr HJ; Scherübl H
    Eur J Gastroenterol Hepatol; 2001 Apr; 13(4):405-11. PubMed ID: 11338071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors.
    Hasegawa T; Yamao K; Hijioka S; Bhatia V; Mizuno N; Hara K; Imaoka H; Niwa Y; Tajika M; Kondo S; Tanaka T; Shimizu Y; Kinoshita T; Kohsaki T; Nishimori I; Iwasaki S; Saibara T; Hosoda W; Yatabe Y
    Endoscopy; 2014 Jan; 46(1):32-8. PubMed ID: 24218309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification.
    Raverot G; Dantony E; Beauvy J; Vasiljevic A; Mikolasek S; Borson-Chazot F; Jouanneau E; Roy P; Trouillas J
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3368-3374. PubMed ID: 28651368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma.
    Zhou HH; Liu LY; Yu GH; Qu GM; Gong PY; Yu X; Yang P
    Anticancer Res; 2017 Aug; 37(8):4529-4537. PubMed ID: 28739749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.
    Voss SM; Riley MP; Lokhandwala PM; Wang M; Yang Z
    Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of CD133 in neuroendocrine neoplasms of the digestive tract: a detailed immunohistochemical analysis.
    Mia-Jan K; Munkhdelger J; Lee MR; Ji SY; Kang TY; Choi E; Cho MY
    Tohoku J Exp Med; 2013 Apr; 229(4):301-9. PubMed ID: 23615455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors.
    Chi Y; Du F; Zhao H; Wang JW; Cai JQ
    World J Gastroenterol; 2014 Nov; 20(43):16252-7. PubMed ID: 25473180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
    Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
    Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognostic significance of a newly proposed grading and scoring system in stage I pulmonary adenocarcinoma].
    Ding FG; Liu B; Zhang XH; Xu Y; Yu B; Zhang RS; He Y; Ma HH; Lu ZF; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):145-50. PubMed ID: 22800475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Prognostic Value of Circulating Tumor Cells in Asian Neuroendocrine Tumors.
    Hsieh JC; Chen GY; Jhou DD; Chou WC; Yeh CN; Hwang TL; Lin HC; Chu HC; Wang HM; Yen TC; Chen JS; Wu MH
    Sci Rep; 2019 Dec; 9(1):19917. PubMed ID: 31882775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of Ki-67 indices from biopsy and resection specimens of neuroendocrine tumours.
    Barnes J; Johnson SJ; French JJ
    Ann R Coll Surg Engl; 2017 Mar; 99(3):193-197. PubMed ID: 27490982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Grading the neuroendocrine tumors of the lung: an evidence-based proposal.
    Rindi G; Klersy C; Inzani F; Fellegara G; Ampollini L; Ardizzoni A; Campanini N; Carbognani P; De Pas TM; Galetta D; Granone PL; Righi L; Rusca M; Spaggiari L; Tiseo M; Viale G; Volante M; Papotti M; Pelosi G
    Endocr Relat Cancer; 2014 Feb; 21(1):1-16. PubMed ID: 24344249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report.
    Rindi G; Bordi C; La Rosa S; Solcia E; Delle Fave G; ;
    Dig Liver Dis; 2011 Mar; 43 Suppl 4():S356-60. PubMed ID: 21459341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.
    Pape UF; Berndt U; Müller-Nordhorn J; Böhmig M; Roll S; Koch M; Willich SN; Wiedenmann B
    Endocr Relat Cancer; 2008 Dec; 15(4):1083-97. PubMed ID: 18603570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.